Artificial Intelligence in Retrosynthesis Prediction and its Applications in Medicinal Chemistry

IF 6.8 1区 医学 Q1 CHEMISTRY, MEDICINAL Journal of Medicinal Chemistry Pub Date : 2025-01-30 DOI:10.1021/acs.jmedchem.4c02749
Lanxin Long, Rui Li, Jian Zhang
{"title":"Artificial Intelligence in Retrosynthesis Prediction and its Applications in Medicinal Chemistry","authors":"Lanxin Long, Rui Li, Jian Zhang","doi":"10.1021/acs.jmedchem.4c02749","DOIUrl":null,"url":null,"abstract":"Retrosynthesis is a strategy to analyze the synthetic routes for target molecules in medicinal chemistry. However, traditional retrosynthesis predictions performed by chemists and rule-based expert systems struggle to adapt to the vast chemical space of real-world scenarios. Artificial intelligence (AI) has revolutionized retrosynthesis prediction in recent decades, significantly increasing the accuracy and diversity of predictions for target compounds. Single-step AI-driven retrosynthesis models can be generalized into three types based on their dependence on predefined reaction templates (template-based, semitemplate-based methods, template-free models), with respective advantages and limitations, and common challenges that limit their medicinal chemistry applications. Moreover, there are relatively inadequate multi-step retrosynthesis methods, which lack strong links with single-step methods. Herein, we review the recent advancements in AI applications for retrosynthesis prediction by summarizing related techniques and the landscape of current representative retrosynthesis models and propose feasible solutions to tackle existing problems and outline future directions in this field.","PeriodicalId":46,"journal":{"name":"Journal of Medicinal Chemistry","volume":"17 1","pages":""},"PeriodicalIF":6.8000,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.jmedchem.4c02749","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Retrosynthesis is a strategy to analyze the synthetic routes for target molecules in medicinal chemistry. However, traditional retrosynthesis predictions performed by chemists and rule-based expert systems struggle to adapt to the vast chemical space of real-world scenarios. Artificial intelligence (AI) has revolutionized retrosynthesis prediction in recent decades, significantly increasing the accuracy and diversity of predictions for target compounds. Single-step AI-driven retrosynthesis models can be generalized into three types based on their dependence on predefined reaction templates (template-based, semitemplate-based methods, template-free models), with respective advantages and limitations, and common challenges that limit their medicinal chemistry applications. Moreover, there are relatively inadequate multi-step retrosynthesis methods, which lack strong links with single-step methods. Herein, we review the recent advancements in AI applications for retrosynthesis prediction by summarizing related techniques and the landscape of current representative retrosynthesis models and propose feasible solutions to tackle existing problems and outline future directions in this field.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
人工智能在药物化学逆转录预测中的应用
反合成是药物化学中分析靶分子合成途径的一种策略。然而,传统的由化学家和基于规则的专家系统进行的逆合成预测很难适应现实世界中广阔的化学空间。近几十年来,人工智能(AI)已经彻底改变了反合成预测,显著提高了目标化合物预测的准确性和多样性。基于对预定义反应模板的依赖,单步人工智能驱动的反合成模型可以归纳为三种类型(基于模板的方法、基于半模板的方法和无模板的模型),它们各自具有优势和局限性,以及限制其药物化学应用的共同挑战。此外,多步反合成方法相对不足,缺乏与单步法的紧密联系。在此,我们通过总结相关技术和当前代表性的反合成模型的概况,回顾了人工智能在反合成预测中的应用的最新进展,并提出了可行的解决方案,以解决存在的问题,并概述了该领域的未来发展方向。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry 医学-医药化学
CiteScore
4.00
自引率
11.00%
发文量
804
审稿时长
1.9 months
期刊介绍: The Journal of Medicinal Chemistry is a prestigious biweekly peer-reviewed publication that focuses on the multifaceted field of medicinal chemistry. Since its inception in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry, it has evolved to become a cornerstone in the dissemination of research findings related to the design, synthesis, and development of therapeutic agents. The Journal of Medicinal Chemistry is recognized for its significant impact in the scientific community, as evidenced by its 2022 impact factor of 7.3. This metric reflects the journal's influence and the importance of its content in shaping the future of drug discovery and development. The journal serves as a vital resource for chemists, pharmacologists, and other researchers interested in the molecular mechanisms of drug action and the optimization of therapeutic compounds.
期刊最新文献
A Novel FXR-Targeted DUBTAC and Its Applications in Cholestasis Therapy. Design, Synthesis, and Evaluation of Phenylpyrrole Derivatives as Small-Molecule Activators of BAX. Discovery of 1,2,3,4-Tetrahydrochromeno[3,4-c]pyridin-5-one Derivatives as Novel MTHFD Inhibitors for the Treatment of Acute Myeloid Leukemia. Antitumor Cytisine-Platinum(IV) Prodrugs Potentiate Crosstalk between Endoplasmic Reticulum and Mitochondria through Calcium Overload Accompanied by Immunogenic Cell Death. Discovery of a Potent RXRγ Degrader WCF-598 for the Treatment of Castration-Resistant Prostate Cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1